510(k) K972986— ACCURUN 140 RUBELLA IGG POSITIVE CONTROL

Substantially Equivalent

Boston Biomedica, Inc.

Clearance details

Applicant: Boston Biomedica, Inc.
Product code: Code MJX
Advisory panel: Clinical Chemistry
Date received: 1997-08-11
Decision date: 1997-10-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: West Bridgewater, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.